Clinical Trial Update: A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study evaluating glycopyrrolate for axillary hyperhidrosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• Glycopyrrolate (glycopyrrolate)

Snippet

Sponsor: Journey Medical Corporation | Conditions: Hyperhidrosis | Phase 2 | Status: COMPLETED | Results posted: 2018-09-13